These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16864905)

  • 21. s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study.
    Rhodus N; Dahmer L; Lindemann K; Rudney J; Mathur A; Bereuter J
    Clin Oral Investig; 1998 Dec; 2(4):191-6. PubMed ID: 10388393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristic changes of saliva and taste in burning mouth syndrome patients.
    Imura H; Shimada M; Yamazaki Y; Sugimoto K
    J Oral Pathol Med; 2016 Mar; 45(3):231-6. PubMed ID: 26293497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances.
    Hershkovich O; Nagler RM
    Arch Oral Biol; 2004 Jul; 49(7):515-22. PubMed ID: 15126133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary and serum levels of substance P, neurokinin A and calcitonin gene related peptide in burning mouth syndrome.
    Boras VV; Savage NW; Brailo V; Lukac J; Lukac M; Alajbeg IZ
    Med Oral Patol Oral Cir Bucal; 2010 May; 15(3):e427-31. PubMed ID: 20038912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study.
    Boucher Y; Braud A; Dufour E; Agbo-Godeau S; Baaroun V; Descroix V; Guinnepain MT; Ungeheuer MN; Ottone C; Rougeot C
    Clin Oral Investig; 2017 Sep; 21(7):2157-2164. PubMed ID: 27834029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome].
    Xia J; Lin M; Jin Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Oct; 21(5):377-8. PubMed ID: 14650995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
    Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
    Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva on the oral mucosa and whole saliva in women diagnosed with burning mouth syndrome.
    Acharya S; Hägglin C; Jontell M; Wenneberg B; Ekström J; Carlén A
    Oral Dis; 2018 Nov; 24(8):1468-1476. PubMed ID: 29917294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome.
    Zidverc-Trajkovic J; Stanimirovic D; Obrenovic R; Tajti J; Vécsei L; Gardi J; Németh J; Mijajlovic M; Sternic N; Jankovic L
    J Oral Pathol Med; 2009 Jan; 38(1):29-33. PubMed ID: 19192048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a Homemade Salivary Substitute Prepared Using Chamomile (
    Aitken-Saavedra J; Chaves Tarquinio SB; De Oliveira da Rosa WL; Fernandes da Silva A; Almeida Machado BM; Santos Castro I; Oliveira Wennesheimer A; Morales-Bozo I; Uchoa Vasconcelos AC; Neutzling Gomes AP
    J Altern Complement Med; 2020 Sep; 26(9):799-806. PubMed ID: 32924561
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative Analysis of Psychological, Hormonal, and Genetic Factors Between Burning Mouth Syndrome and Secondary Oral Burning.
    das Neves de Araújo Lima E; Barbosa NG; Dos Santos AC; AraújoMouraLemos TM; de Souza CM; Trevilatto PC; da Silveira EJ; de Medeiros AM
    Pain Med; 2016 Sep; 17(9):1602-11. PubMed ID: 26849950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in unstimulated salivary flow rate in burning mouth syndrome.
    Poon R; Su N; Ching V; Darling M; Grushka M
    Br Dent J; 2014 Oct; 217(7):E14. PubMed ID: 25303607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome.
    Kim HI; Kim YY; Chang JY; Ko JY; Kho HS
    Oral Dis; 2012 Sep; 18(6):613-20. PubMed ID: 22533537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary metabolomics of burning mouth syndrome: A cross-sectional study.
    Ye L; Dai Q; Hou F; Wu C; Qiu X; Yuan P; Chen F; Meng Y; Feng X; Jiang L
    Arch Oral Biol; 2022 Dec; 144():105552. PubMed ID: 36279827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome.
    Kang JH; Kim YY; Chang JY; Kho HS
    Arch Oral Biol; 2017 Jun; 78():58-64. PubMed ID: 28199919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic profiling of whole-saliva reveals correlation between Burning Mouth Syndrome and the neurotrophin signaling pathway.
    Krief G; Haviv Y; Deutsch O; Keshet N; Almoznino G; Zacks B; Palmon A; Aframian DJ
    Sci Rep; 2019 Mar; 9(1):4794. PubMed ID: 30886243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot study.
    Barry A; O'Halloran KD; McKenna JP; McCreary C; Downer EJ
    J Oral Pathol Med; 2018 Feb; 47(2):158-165. PubMed ID: 29194773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of peri-implant clinical and radiographic inflammatory parameters and whole salivary destructive inflammatory cytokine profile among obese and non-obese men.
    Abduljabbar T; Al-Sahaly F; Kellesarian SV; Kellesarian TV; Al-Anazi M; Al-Khathami M; Javed F; Vohra F
    Cytokine; 2016 Dec; 88():51-56. PubMed ID: 27560655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study.
    Amenábar JM; Pawlowski J; Hilgert JB; Hugo FN; Bandeira D; Lhüller F; Lopes de Souza MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):460-5. PubMed ID: 18329582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and control subjects.
    Alajbeg IZ; Vrbanovic E; Alajbeg I; Orabovic I; Naka K; Mrla A; Boucher Y
    Clin Oral Investig; 2024 Apr; 28(5):246. PubMed ID: 38589630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.